Article contents
Out-patients' perceptions of the clinical and psychosocial effects of neuroleptic medication
Published online by Cambridge University Press: 02 January 2018
Extract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
While research into the effectiveness of neuroleptic medication consistently demonstrates its value in improving psychotic symptoms, and in the prevention of relapse, the treatment continues to generate controversy. Indeed, McClelland (1989) has recently asserted that this treatment of choice is “an indispensable evil”; “indispensable” by virtue of its clinical effectiveness, and “evil” because of the wide range of adverse and distressing side effects experienced by patients.
- Type
- Articles
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Copyright
- Copyright © Royal College of Psychiatrists, 1990
References
Gardos, G. & Cole, J. (1976) Maintenance antipsychotic therapy: Is the cure worse than the disease?
American Journal of Psychiatry, 133, 32–36.Google ScholarPubMed
Hogarty, G. E.
et al (1974) Drug and sociotherapy in the aftercare of schizophrenic patients. Archives of General Psychiatry, 31, 603–608.CrossRefGoogle ScholarPubMed
McClelland, H. A. (1989) Brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients: Comment. British Journal of Psychiatry, 155, 702–703.CrossRefGoogle Scholar
You have
Access
Open access
- 3
- Cited by
eLetters
No eLetters have been published for this article.